Clinical trials
Liver Cirrhosis trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 12 |
| 2020 | 14 |
| 2021 | 13 |
| 2022 | 11 |
| 2023 | 13 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Liver and Biliary Sciences, India | 22 |
| Seoul National University Hospital | 5 |
| Air Force Military Medical University, China | 4 |
| Shanghai Zhongshan Hospital | 4 |
| Third Affiliated Hospital, Sun Yat-Sen University | 3 |
| Beijing Friendship Hospital | 2 |
| Qilu Hospital of Shandong University | 2 |
| West China Hospital | 2 |
| ALDO TORRE DELGADILLO | 1 |
| Addis Ababa University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 107 |
| Hypertension, Portal | 13 |
| Carcinoma, Hepatocellular | 12 |
| Fibrosis | 9 |
| Sarcopenia | 8 |
| Hepatitis B | 6 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Esophageal and Gastric Varices | 5 |
| Fatty Liver | 5 |
| Liver Diseases | 4 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.